Skip to content

Joanna Kuć

9 papers in the library · 89 citations · publishing 2021-2026

Papers

Sort Most recent Most cited

Perspectives on Meditation-based Preparation for Psychedelic Experiences: Insights from Practitioners with Combined Meditation and Psychedelic Experience

Mindfulness August 15, 2026 Rosalind McAlpine, Merve Utanğaç, Joanna Kuć et al.

Abstract Objectives Emerging research suggests that meditation may support more beneficial psychedelic experiences while reducing the likelihood of lasting negative effects, yet its specific preparatory benefits remain underexplored. This study aimed to investigate the perceived utility of meditation as a preparatory tool for enhancing positive outcomes and reducing negative effects during...

Speech markers of psychological change following a psychedelic 5-MeO-DMT retreat.

Journal of psychopharmacology (Oxford, England) May 23, 2026 Joanna Kuć, Rosalind McAlpine, Amelia Sellers et al.

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), a potent, short-acting psychedelic, induces profound shifts in cognition, affect, and self-awareness. Because language explicitly expresses these domains and voice implicitly conveys them, both may serve as potential 'biomarkers' of behavioural change. This study introduces a novel framework for analysing baseline language and vocal features, pre-...

Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.

BMJ Open March 12, 2026 Rosalind McAlpine, Magdalena Jaglinska, Krisztina Jedlovszky et al.

Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application. Digital health interventions have the potential to address this limitation by providing structured, accessible and scalable preparation solutions. This randomised controlled feasibility trial aims to evaluate the...

Speech markers of psychedelic-induced psychological change

bioRxiv April 21, 2025 Joanna Kuć, Rosalind McAlpine, Amelia Sellers et al. preprint

Abstract 5-MeO-DMT, a potent, short-acting psychedelic, induces profound shifts in cognition, affect, and self-awareness. Because language explicitly expresses these domains and voice implicitly conveys them, both may serve as potential ‘biomarkers’ of behavioural change. This study introduces a novel framework for analysing baseline language and vocal features, pre- to post-psychedelic...

Practitioner perspectives on meditation-based preparation for psychedelic experiences

February 6, 2025 Rosalind McAlpine, Merve Utanğaç, Joanna Kuć et al. 2 citations preprint

The potential of meditation as a preparatory tool for psychedelic experiences lacks empirical investigation. We surveyed experienced practitioners (N=123) with substantial histories in both meditation and psychedelic use to examine meditation’s role in psychedelic preparation. Respondents expected meditation training to primarily enhance acceptance and present-moment focus during psychedelic...

The age of spiritual machines: Language quietus induces synthetic altered states of consciousness in artificial intelligence

arXiv (Cornell University) September 30, 2024 Jeremy I Skipper, Joanna Kuć, Gregory M. Cooper et al.

How is language related to consciousness? Language functions to categorise perceptual experiences (e.g., labelling interoceptive states as 'happy') and higher-level constructs (e.g., using 'I' to represent the narrative self). Psychedelic use and meditation might be described as altered states that impair or intentionally modify the capacity for linguistic categorisation. For example,...

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

J Psychopharmacol January 27, 2024 Jessica Barbut Siva, Tommaso Barba, Hannes Kettner et al. 29 citations

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing

Psychopharmacology August 22, 2023 Robert F. Dougherty, Patrick Clarke, Merve Atli et al. 21 citations

Abstract Rationale Therapeutic administration of psychedelics has shown significant potential in historical accounts and recent clinical trials in the treatment of depression and other mood disorders. A recent randomized double-blind phase-IIb study demonstrated the safety and efficacy of COMP360, COMPASS Pathways’ proprietary synthetic formulation of psilocybin, in participants with...

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.

Psychopharmacology (Berl) November 4, 2021 Joanna Kuć, Hannes Kettner, Fernando E. Rosas et al. 37 citations

RATIONALE: Classic psychedelics are currently being studied as novel treatments for a range of psychiatric disorders. However, research on how psychedelics interact with other psychoactive substances remains scarce. OBJECTIVES: The current study aimed to explore the subjective effects of psychedelics when used alongside cannabis. METHODS: Participants (n = 321) completed a set of online surveys...